<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> is a dominantly inherited clinically variable multisystemic disorder, and has been found to be caused by heterozygosity for a trinucleotide repeat expansion mutation in the 3' untranslated region of a protein kinase gene (DM kinase) </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanisms by which the expanded repeat in DNA results in a dominant biochemical defect and the varied clinical phenotype, is not known </plain></SENT>
<SENT sid="2" pm="."><plain>We have recently proposed a model where disease pathogenesis may occur at the <z:chebi fb="40" ids="33697">RNA</z:chebi> level in myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath>: the mutant DM kinase <z:chebi fb="40" ids="33697">RNA</z:chebi> with the expansion mutation may disrupt cellular <z:chebi fb="40" ids="33697">RNA</z:chebi> metabolism in some general manner, as evidenced by defects in <z:chebi fb="40" ids="33697">RNA</z:chebi> processing of the <z:mpath ids='MPATH_458'>normal</z:mpath> DM kinase gene in heterozygous patients (dominant negative <z:chebi fb="40" ids="33697">RNA</z:chebi> mutation) </plain></SENT>
<SENT sid="3" pm="."><plain>Here we further test this hypothesis by measuring <z:chebi fb="40" ids="33697">RNA</z:chebi> metabolism of other genes in patient muscle biopsies (nine <z:hpo ids='HP_0003581'>adult onset</z:hpo> myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> patients, two <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> patients, four <z:mpath ids='MPATH_458'>normal</z:mpath> controls, and four myopathic controls) </plain></SENT>
<SENT sid="4" pm="."><plain>We focused on the insulin receptor gene because of the documented <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> of DM patients </plain></SENT>
<SENT sid="5" pm="."><plain>We show that there is a significant decrease in insulin receptor <z:chebi fb="40" ids="33697">RNA</z:chebi> in both total <z:chebi fb="40" ids="33697">RNA</z:chebi> and <z:chebi fb="40" ids="33697">RNA</z:chebi> polyA+ pools relative to <z:mpath ids='MPATH_458'>normal</z:mpath> and myopathic control muscles (P &lt; 0.002), measured relative to both dystrophin <z:chebi fb="40" ids="33697">RNA</z:chebi> and muscle <z:chebi fb="199" ids="26708">sodium</z:chebi> channel <z:chebi fb="40" ids="33697">RNA</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>We also show reductions in insulin receptor protein </plain></SENT>
<SENT sid="7" pm="."><plain>Our results reinforce the concept of a generalized <z:chebi fb="40" ids="33697">RNA</z:chebi> metabolism defect in myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath>, and offer a possible molecular mechanism for the increased <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> observed in many myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> patients </plain></SENT>
</text></document>